Chlorogenic acid ameliorates non-proliferative diabetic retinopathy via alleviating retinal inflammation through targeting TNFR1 in retinal endothelial cells
Authors:
- 18 August 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 141, 112929
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Chlorogenic acid improves diabetic retinopathy by alleviating blood‐retinal‐barrier dysfunction via inducing Nrf2 activationPhytotherapy Research, 2022
- A review of traditional Chinese medicine on treatment of diabetic retinopathy and involved mechanismsBiomedicine & Pharmacotherapy, 2020
- Endothelial Notch activation promotes neutrophil transmigration via downregulating endomucin to aggravate hepatic ischemia/reperfusion injuryScience China Life Sciences, 2020
- Lonicerae japonicae flos and Lonicerae flos: a systematic review of ethnopharmacology, phytochemistry and pharmacologyPhytochemistry Reviews, 2019
- Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-ĸB pathwaysInternational Immunopharmacology, 2018
- Modulation of microglia in the retina: new insights into diabetic retinopathyActa Diabetologica, 2017
- Astrocytic and microglial response in experimentally induced diabetic rat brainMetabolic Brain Disease, 2014
- Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicineJournal of Ethnopharmacology, 2011
- Mechanisms of leukocyte migration across the blood–retina barrierSeminars in Immunopathology, 2008
- TNFR1-induced NF-κB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cellsCellular Signalling, 2007